ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 2035

$406K Total Retail Price of All Prescriptions

Rank: 463 out of 2035

273 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

37% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 9,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 786 589 1 1
HYDROCODONE-ACETAMINOPHEN 568 459 S3 2 2
METOPROLOL TARTRATE 452 433 3 8
AMLODIPINE BESYLATE 446 405 4 6
LISINOPRIL 422 337 5 3
FUROSEMIDE 374 307 6 7
OMEPRAZOLE 303 229 7 5
METFORMIN HCL 265 179 8 9
RANITIDINE HCL 253 215 9 28
LEVOTHYROXINE SODIUM 236 187 10 4
GABAPENTIN 235 187 11 14
HYDROCHLOROTHIAZIDE 199 150 12 12
PROAIR HFA 174 129 13 31
DONEPEZIL HCL 170 145 14 24
ZOLPIDEM TARTRATE 156 120 15 21
POTASSIUM CHLORIDE 149 125 16 18
IBUPROFEN 148 93 17 43
ACETAMINOPHEN-CODEINE 147 132 S3 18 52
ISOSORBIDE MONONITRATE ER 132 114 19 32
CLOPIDOGREL 125 98 20 30
ALLOPURINOL 124 107 21 34
TRAMADOL HCL 119 89 22 19
LOSARTAN POTASSIUM 119 117 22 15
CLONIDINE HCL 117 104 24 61
GLIPIZIDE 114 73 25 54
VENTOLIN HFA 110 102 26 80
ATENOLOL 105 88 27 10
HYDRALAZINE HCL 105 92 27 45
ADVAIR DISKUS 100 100 29 38
CARVEDILOL 99 63 30 22
GLYBURIDE 95 85 R 31 74
KLOR-CON 8 88 66 32 258
WARFARIN SODIUM 86 81 33 11
NITROSTAT 85 73 34 167
SERTRALINE HCL 84 58 35 23
INSULIN SYRINGE 82 75 36 97
BETAMETHASONE DIPROPIONATE 80 54 37 246
ALENDRONATE SODIUM 78 47 38 27
ALCOHOL PREP PADS 76 60 39 262
TAMSULOSIN HCL 73 68 40 25
ATORVASTATIN CALCIUM 73 68 40 13
PLAVIX 68 52 42 49
SINGULAIR 67 59 43 119
METOPROLOL SUCCINATE 66 53 44 16
AZITHROMYCIN 61 48 45 39
MEGESTROL ACETATE 60 49 R 46 175
PRAVASTATIN SODIUM 59 41 47 17
OXYBUTYNIN CHLORIDE 59 49 47 102
NEXIUM 58 43 49 51
CYCLOBENZAPRINE HCL 56 26 R 50 64
FAMOTIDINE 56 56 50 71
TRIAMTERENE-HCTZ 56 56 50 35
ENALAPRIL MALEATE 55 41 53 60
PANTOPRAZOLE SODIUM 53 36 54 42
DIGOXIN 52 48 55 67
DETROL LA 52 51 55 237
DIOVAN 51 30 57 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.